Company Search:
Advanced Search
Sponsored Links
Mallinckrodt PLC Company Snapshot
Mallinckrodt PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mallinckrodt PLC with three other companies in this sector in the United States: Regeneron Pharmaceuticals Incorporated (2015 sales of $4.10 billion of which 100% was Research & Development), Alexion Pharmaceuticals, Inc. ($2.60 billion of which 100% was Therapeutic Products), and Endo International PLC ($3.27 billion of which 51% was Generics).

Sales Analysis. Mallinckrodt PLC reported sales of $3.35 billion for the fiscal year ending September of 2015. This represents an increase of 31.7% versus 2014, when the company's sales were $2.54 billion. This was the fourth straight year of sales growth at Mallinckrodt PLC.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mallinckrodt PLC
  Stock Performance Chart for Mallinckrodt PLC
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 62.10
(Figures in U.S. Dollars)
1 Week -5.7%   13 Weeks -18.6%  
4 Weeks -6.6%   52 Weeks -5.6%  
Mallinckrodt PLC Key Data:
  Ticker: MNK Country: Ireland
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,346,900,000
(Year Ending Jan 2016).
Employees: 5,700
  Currency: U.S. Dollars Market Cap: 6,688,997,172
  Fiscal Yr Ends: September Shares Outstanding: 107,713,320
  Share Type: Common Closely Held Shares: 508,192
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.